Last reviewed · How we verify

Lactoferrin

Cairo University · FDA-approved active Small molecule

Lactoferrin is a Small molecule drug developed by Cairo University. It is currently FDA-approved. Also known as: Pravotin sachets, Bovine Lactoferrin, Standard of care treatment regimens, Pravotin.

At a glance

Generic nameLactoferrin
Also known asPravotin sachets, Bovine Lactoferrin, Standard of care treatment regimens, Pravotin, MamyVital
SponsorCairo University
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Lactoferrin

What is Lactoferrin?

Lactoferrin is a Small molecule drug developed by Cairo University.

Who makes Lactoferrin?

Lactoferrin is developed and marketed by Cairo University (see full Cairo University pipeline at /company/cairo-university).

Is Lactoferrin also known as anything else?

Lactoferrin is also known as Pravotin sachets, Bovine Lactoferrin, Standard of care treatment regimens, Pravotin, MamyVital.

What development phase is Lactoferrin in?

Lactoferrin is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing